Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Argos Therapeutics Inc (NASDAQ:ARGS)

0.1348
Delayed Data
As of Jan 18
 -2.56 / -95.00%
Today’s Change
0.13
Today|||52-Week Range
106.00
-95.51%
Year-to-Date
No recent news for Argos Therapeutics Inc.

Today’s Trading

Previous close2.70
Today’s open0.15
Day’s range0.13 - 0.16
Volume17,910,299
Average volume (3 months)245,668
Market cap$14.2M
Data as of 3:59pm ET, 01/18/2018

Growth & Valuation

Earnings growth (last year)+54.64%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+82.41%
P/E ratioNM
Price/Sales165.87
Price/Book1.08

Competitors

 Today’s
change
Today’s
% change
HEBHemispherx Biopharma...-0.01-1.78%
RPRXRepros Therapeutics ...+0.00+0.06%
ITUSITUS Corp+0.01+0.22%
ACHVAchieve Life Science...+0.06+4.11%
Data as of 8:00pm ET, 01/18/2018

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$945.5K
Annual profit (last year)-$53.0M
Net profit margin-5,608.66%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jeffrey D. Abbey
CFO, Vice President &
Investor Relations Contact
Richard D. Katz
Corporate headquarters
Durham, North Carolina

Forecasts